Ceftazidime-Induced Neurotoxicity Management

Supportive Care

• The American Society of Clinical Oncology recommends administering benzodiazepines for seizure activity if present, and monitoring and correcting electrolyte imbalances that may exacerbate neurological symptoms 1

Clinical Context and Risk Factors

• Renal impairment is the primary risk factor due to drug accumulation, even when dosing is appropriately adjusted, with a risk of neurotoxicity occurring despite appropriate renal dose adjustments in 26% of cases 2

Alternative Antibiotic Selection

• The Infectious Diseases Society of America suggests considering switching to cefotaxime or ceftriaxone, which have both hepatic and renal excretion pathways and lower neurotoxicity risk, and meropenem is an excellent alternative with the same antimicrobial spectrum but significantly lower neurotoxicity (16% relative pro-convulsive activity compared to ceftazidime) 3
• Cefoxitin has the lowest seizure risk among beta-lactams (1.8% compared to penicillin G) if a cephalosporin is required 3